Celgene Gains 20%, Bristol-Myers Down 13% on Merger News - Adviser Investments

Celgene Gains 20%, Bristol-Myers Down 13% on Merger News

Chris Hagan, vice president at Adviser Investments, has the market analysis for Thursday, January 3. Nine of the S&P 500’s 11 sectors finished lower today, with technology stocks down about 5%. Airline stocks also fell; Delta Air Lines led those declines at 9% and American Airlines close behind, down 8%. Meanwhile, the biotechnology sector saw gains following the $74 billion Bristol-Myers Squibb-Celgene merger announcement. Celgene’s stock gained more than 20%, while Bristol-Myers Squibb fell 13% on the news.

Recent Videos

View All Videos

Oil Rises 2% After Tanker Attacks

Consumer Price Index Shows Muted Inflation

Small Business Optimism Index Higher Than Expected

Oil Prices Continue to Fall

85 Wells Avenue, Suite 109 Newton, MA, 02459

info@adviserinvestments.com 1.800.492.6868

Adviser Investments' logo is a registered trademark of Adviser Investments, LLC.